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Abstract
Background: Poor compliance to highly active antiretroviral therapy (HAART) can result in the poor quality of life in
children living with Human immunodeficiency virus/Acquired immunodeficiency syndrome (HIV/AIDS) because of
low plasma drug concentration and the possibility of drug resistance. This study evaluates the response of
caregivers for determination of adherence and the four quality of life domains in children (aged 14 years and
under) on HAART.
Methods: We conducted a cross-sectional study of 188 children, each accompanied by their caregivers at Ola
During Children’s Hospital and Makeni Government Hospital between September and November 2016. Adherence
to HAART and Quality of life was assessed using the WHO Quality of life summary questionnaire (WHOQOL-BREF).
We obtained ethical approval from the Sierra Leone Ethics and Scientific Review Committee.
Results: The study revealed 5.9% adherence amongst paediatric patients, and a strong association of adherent
patients(p = 0.019*) to the physical health domain (mean = 64.61 SD = 8.1). Caregiver HIV status showed a strong
association with the physical (mean = 58.3, SD = 11.7 and p = 0.024*), and psychological health domains (mean =
68.2, SD = 14.7 and p = 0.001). Caregiver type (mother/father/sibling) accompanying child to hospital also showed
strong associated with the physical (mean = 58.0, SD = 10.6, p < 0.001), psychological (mean 68.2 SD = 14.81
p < 0.001) and environmental health domains (mean = 59.7, SD = 13.47, p < 0.001). Further regression analysis
showed a strong association with physical health domain for HIV positive caregivers (p = 0.014) and adherent
paediatric patients (p = 0.005). Nuclear family also showed a strong association with psychological (p < 0.001) and
environmental (p = 0.001) health domains.
Conclusion: This study showed a strong association between the quality of life domains and the involvement of
nuclear family caregiver, HIV-positive caregiver and adherence to HAART. Our study suggests that the involvement
of any member of the nuclear family, HIV positive parents and patient adherence to therapy can improve the
quality of life of paediatric HIV/AIDS patients on highly active antiretroviral therapy in the two hospitals.
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Background
Children and adolescents make up 33.3% of the world’s
population [1]. In 2014, two million six hundred chil-
dren aged 0 to 15 years were known to be living with
HIV/AIDS globally with only a third of them accessing
antiretroviral treatment. Human immunodeficiency
virus/Acquired immunodeficiency syndrome (HIV/
AIDS) is the second most significant cause of death
among adolescents and a leading cause of death in Af-
rica among adolescents, most of whom got HIV as in-
fants [2]. In 2016, United Nations Joint Program on
HIV/AIDS (UNAIDS) estimated that 28% of children
aged 14 years and under are living with HIV/AIDS in
Western and Central Africa, with 40% of these children
dying from AIDS-related illnesses [3].
Studies have shown that non-adherence to highly ac-
tive antiretroviral therapy (HAART) is associated with
poor quality of life [4]. In contrast, the provision of ap-
propriate HIV care can lead to an improvement in
health-related quality of life among people living with
HIV/AIDS [5]. Similarly, studies using clinical and im-
munological markers have shown that early introduction
of highly active antiretroviral therapy in children with
HIV/AIDS can have a positive influence on their quality
of life [6]. Good clinical outcomes have also been ob-
served as a direct effect of HAART adherence with a
known reduction in morbidity and mortality in children
infected with HIV in Kenya [7]. Non-adherence is de-
fined as the discontinuation of part or all of the treat-
ment regimen that includes missing dose, under-dose,
over-dose and drug holidays [8]. The key drivers of non-
adherence include lack of insight, forgetfulness, busy
work schedule, distance to clinic and medication beliefs,
and it has been shown that African states do share simi-
lar drivers of non-adherence with western nations [9].
The International Association of Physicians in AIDS
Care recommends routine monitoring of adherence to
evaluate adherence interventions and prevent drug re-
sistance. Studies have also shown that achievement of
good quality of life requires a high level of adherence of
over 95% for paediatric patients on HAART for whom
there is also no specific recommendation for monitoring
adherence [9]. It is known that caregiver estimates for
HAART adherence in children are consistently higher
than adherence by other measures such as pharmacy re-
fill and other new technologies, suggesting that care-
givers may overestimate their child’s adherence.
However, outside funded research settings, new tech-
nologies such as Medication Event Monitoring Systems
are usually too expensive than caregiver estimates [10].
Therefore, despite the limitation associated with care-
giver estimates of adherence, it remains the most widely
used method of adherence in most low and middle-
income countries [11].
HIV prevalence in Sierra Leone is 1.5%, and preva-
lence among children is 5.8% [12]. Sierra Leone also has
37.7% antiretroviral therapy coverage among all age
groups, with an estimated 383 children receiving anti-
retroviral therapy (ART) and 1810 children in need of
antiretroviral therapy [13].
The 2014 Ebola epidemic resulted in a reduction in ac-
cess to HIV/AIDS care because most parents were un-
willing to seek care at hospitals due to Ebola-related
stigma and the fear associated with becoming infected
with the Ebola virus as well as mistrust for healthcare
workers [14]. The end of the Ebola outbreak saw the im-
plementation of post-Ebola interventions aimed at im-
proving healthcare service utilisation among people
living with HIV/AIDS (PLHIV). These interventions in-
clude identification of loss to treatment follow-up and
public awareness [13]. Most HIV/AIDS studies in Sierra
Leone are focused on knowledge, attitudes and behav-
iour of high-risk groups like sex workers and youths
[15–17]. Currently, there is little or no research evidence
on the level of adherence and the quality of life of chil-
dren living with HIV/AIDS (CLHIV) in Sierra Leone.
This study adds to the contemporary HIV/AIDS litera-
ture in Sierra Leone and in Africa, by assessing adher-
ence to HAART among paediatric HIV/AIDS patients
through the perception of their caregivers. Our study
also sought to determine the association between the
demographic and health-related factors of caregivers and
the quality of life of paediatric HIV/AIDS patients in
two public hospitals in Sierra Leone.
Methods
Study design, setting and population
We conducted cross-sectional study of caregivers ac-
companying HIV-infected children aged 14 years and
under, between 1st September and 30th November
2016. A caregiver was defined in our study as a parent
or guardian accompanying HIV-infected children aged
14 years and below.
We conducted our study at the HIV/AIDS clinics of
Ola During Children’s Hospital (ODCH) and Makeni
Government Hospital located in the Western and
Northern regions of Sierra Leone respectively. These
hospitals are the main referral hospitals in two of Sierra
Leone’s four regions. A convenient sampling method
was used to recruit caregivers accompanying HIV-
infected children in our study. All caregivers accom-
panying HIV-infected children who seek care at these
hospitals between the 1st September to 30th November
2016 were invited to take part in the study. At the end
of November 2016, 200 caregivers accompanying HIV-
infected children were invited to participate in the study.
However, only one hundred and two caregivers from
Ola During Children’s Hospital and 86 caregivers from
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Makeni Government Hospital consented to participate
in this study. Nine caregivers at Ola During Children’s
Hospital and three caregivers at Makeni government
Hospital were excluded from the survey because they
did not consent to participate.
Ethical approval
We sought ethical approval for this study from the Si-
erra Leone Ethics and Scientific Review Committee
(SLESRC); Directorate of Policy and Planning, Ministry
of Health and Sanitation (MoHS) and the study was ap-
proved on 1st September 2016 by SLESRC. Study nurses
were trained to use the questionnaire and to behave in
an ethical manner that allows for the appropriate con-
duct of the study. The nurses informed the caregivers/
guardians about the purpose of the survey and that they
had the right to participate or refuse participation in the
study. They were also informed that appropriate treat-
ment would be provided regardless of their refusal to
take part in the study. Each caregiver was asked to sign a
consent form to indicate their willingness to participate
in the study. All data collected were also coded to pre-
vent disclosure of the information to any third party.
Outcome measures and data collection
We used a validated WHO quality of life questionnaire
(WHOQOL-BREF questionnaire) that has been tested in
resource-limited countries [18, 19]. The questionnaire
consisted of three parts, and that include details of the
caregiver, caregiver adherence estimates and quality of
life questions. Interviewer-administered questionnaire
format was used to collect data from caregivers. The
Likert scale used in the WHOQOL-BREF questionnaire
can be seen in Table 1 below.
The "Social domain sex life question was not used for
the adaptation and utilisation of the WHOQOL-BREF
paediatric age group questionnaire in this study because
all of these children are aged 14 years and under and
questions are being responded to, by their caregivers.
The dependent variables in this study were the four
domains (Physical Health, Psychological Health, Envir-
onmental Health and Social Health) of the WHOQOL-
BREF [18, 19].
The independent variables were the demographic vari-
ables adapted from a previous study that measures ad-
herence in paediatric patients [20]. Adherence was
assessed using self-reporting measures for adherence to
Highly Active Antiretroviral Therapy (HAART) by care-
givers, as shown in Table 2 below.
Such measures of adherence are still widely used in
resource-limited countries [21]. However, other stud-
ies showed that caregiver reports could overestimate
the level of adherence in paediatric HIV/AIDS pa-
tients [4, 20].
Four trained data collectors (two nurses working in
each of the two HIV/AIDS clinics at Ola During Chil-
dren’s hospital and Makeni Government hospital) col-
lected the data through interviewer-administered format.
Statistical analysis
Statistical package for social sciences (SPSS version 16.0)
was employed during data analysis. Reliability and valid-
ity of the instrument were done by determining Cron-
bach’s alpha value for which an alpha value greater than
or equals to 0.7 was deemed acceptable [22, 23] while
correlations above 0.4 were considered to be acceptable
[23]. Descriptive statistics were used to analyse categor-
ical and continuous variables. Pearson’s correlation was
used to determine the level of agreement between the
two overall Quality of life questions and the four do-
mains of the WHOQOL-BREF. Chi-square and Fisher’s
exact tests were used to assess the association between
the independent variables and the level of adherence
(dependent variable) of paediatric patients to HAART.
An independent t-test and analysis of variance tests were
used to determine the association between participants’
characteristics and the average quality of life scores
(transformed scores of four domains). Post hoc analysis
was further conducted for domains that showed signifi-
cant difference with caregivers’ or patients’ characteris-
tics. Backward multivariate linear regression was
employed to investigate the relationship between quality
of life and patient characteristic with a P-value less than
0.05 considered statistically significant. For stepwise
multivariate linear regression analysis, caregiver HIV sta-
tus (positive, negative and Don’t Know) was grouped
into binary data as positive and non-positive. The non-
positive data includes the data for a patient with negative
HIV status and patient with no knowledge of their HIV
status. Relationship of caregivers (1-mother/Father/Sib-
ling, 2-cousin/Aunties/uncles, 3-Neighbours/Relatives
outside the home) was analysed as Nuclear family (1)
and Extended family (2, 3) to determine the influence of
close relatives against other family members on the qual-
ity of life of children with HIV/AIDS. The independent
variable (adherence versus non-adherence) was also ana-
lysed to determine the influence on the dependent
Table 1 Five points Likert scale to measure the quality of life






Moderately or neither satisfied nor
dissatisfied or neither poor nor good
or Quite often
Mostly or satisfied or good or
well or very much or Well or
very often
Completely or very satisfied or
very good or very well or
extremely or Always
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variable (quality of life of children with HIV/AIDS) using
the backward linear regression analysis.
Results
Demographic and other related characteristics
Out of the 200 caregivers that were invited, 188 con-
sented to participate, and their data were included in
our final analysis. Table 3 shows that 74.5% of caregivers
were aged 30 years or older, 76.6% of caregivers were fe-
male, 43.6% were HIV positive, and 33% of caregivers do
not know their HIV status. Also, 60.6% of caregivers are
members of the nuclear family. 62.8% of the caregivers
had a problem with keeping to the timing of medication
with 35.1% of this occurring in the morning, and 15.4%
of problems occurring in the evening. More than half
(56.9%) of the caregivers had difficulty in getting their
child to take their medication. Close to two-thirds
(61.7%) of children in this study were less than 5 years,
54.3% of the children were male, and 76.1% of the chil-
dren were involved in an institutional nutritional pro-
gram. Only 5.9% paediatric age group were adherent to
Highly Active Antiretroviral Therapy (HAART) while
94.1% were non-adherent.
Factors affecting non-adherence
The study showed that three factors influenced paediat-
ric HIV patient adherence to HAART, and they include
child-related factors, caregiver related factors and insti-
tutional factors. Formulation problem (72.3%) and bitter
medication (52.7%) were the most common child-related
factors affecting paediatric HIV patient adherence to
HAART. The commonest caregiver related factors were
“didn’t want others to see” (61.7%), “was away from
home” (60.6%), “didn’t have money to take child to the
hospital” (56.9%), “forgetful” (38.8%) and “don’t know
how to use the medication” (11.2%). In the case of insti-
tutional factor, 2.7% stated that “medicine was not avail-
able in the clinic”. (Table 4).
Factors affecting adherence
No Statistical significant association was seen between
independent variables and adherence to HAART
(dependent variable) (Table 5).
Assessment of quality of life in paediatric HIV/AIDs
patient on HAART
Table 6 shows the average transformed scores of the
four different domains with the psychological domain
[63.1(SD 17.7] and the social relationship domain
[44.1(SD 18.2)] being the highest and lowest mean
scores respectively.
Association of independent variables and quality of life
domains
Table 7 shows that there is a statistically significant dif-
ference between caregiver HIV/AIDS status and physical
health (p = 0.024) and psychological health (p < 0.001)
domains. Also, a significant difference was observed be-
tween caregiver type and all the quality of life domains
except social health. In addition, there was a statistically
significant difference between adherence to HAART and
the physical health domain. Participants who were ad-
herent to HAART were more likely to have improved
physical health and Significant difference in social health
was also seen for caregivers accompanying children aged
less than 5 years.
Multivariate backward linear regression model after
adjusting for other covariates revealed significant associ-
ation in physical health domain with HIV status of care-
giver and adherence status. Our study also revealed a
significant association between caregiver type to psycho-
logical health and the environmental health domain.
(Table 8).
Validity and reliability of questionnaire
Pearson’s Correlation was found to be significant for the
four domains (Table 9) and Cronbach’s alpha was found
to be 0.769.
Discussion
This study provides an empirical evidence on the level of
adherence and quality of life as well as their associated
determinants among children living with HIV/AIDS in
Sierra Leone.
Factors affecting non-adherence
The results of this study indicate that non-adherence
among HIV positive paediatric patients was rife. Most
caregivers had problems administering medication to
their children in the morning than at any other time of
the day. Such difficulties may be due to caregivers leav-
ing home early in the morning for work/trade when the
child is asleep or decided to skip dose due to the absence
of food [24]. The key reasons for the high prevalence of
non-adherence in our study were formulation related
factors such as the taste of the medication. Caregiver re-
lated factors were fear of discrimination from others,
lack of support and or fear of disclosure. Institutional
Table 2 Measures of Adherence
Non-adherence: Any indication of missed dose in the past week/month, or a dose more than an hour late.
Adherence: no indication of a missed dose
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factors were an absence of money to take the child to
the hospital, inadequate knowledge on the use of medi-
cation and the shortage of HIV/AIDS drugs in the clinic.
Previous studies had identified these factors affecting ad-
herence [25, 26]. Non-adherence among children with
HIV/AIDS means not achieving the high level of adher-
ence of 95% or more. Non-adherence might result in
sub-therapeutic blood concentrations, treatment failure,
and the emergence of drug resistance with the resulting
burden on the health system due to lengthy hospital stay
and increased healthcare cost.
Therefore, the healthcare team must be involved in
medication counselling for the paediatric age group.
This would possibly require a separate counselling
Table 3 Demographic and other Related Characteristics
Caregiver Age Frequency Percentage
< 30 years 48 25.5







Don’t Know 62 33.0
Caregiver Relationship to Child
Mother/Father/Siblings 114 60.6
Close relatives (Grandparents/Aunties/Uncles) 70 37.2





< 5 years 116 61.7
≥ 5 years 72 38.3
Involved in Nutritional Program
Yes 143 76.1
No 45 23.9
Problem with keeping to time of medication
Yes 118 62.8
No 70 37.2





Not Applicable 70 37.2
Problems in getting child to take medication
Yes 107 56.9
No 81 43.1
Child’s HAART Adherence status
Adherent 11 5.9
Non-Adherent 177 94.1
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session that is focused on assessing adherence of paedi-
atric patient/caregiver, providing information on the use
of medication, possible HAART side effects and contra-
indication aimed at improving the factors affecting pa-
tient adherence to their medication.
There is also the need for the development of health
policies or guidelines in all hospitals that take these fac-
tors (patient, institutional, caregiver) into consideration.
Family support and community sensitisation and aware-
ness are also crucial in preventing the stigma that may
be associated with HIV/AIDS in the society.
Further assessment of demographic characteristic in
our study showed that active involvement of nuclear
family member (Father/Mother/Sibling) presented statis-
tical significant difference in quality of life of paediatric
patients (psychological health and environmental health
domain). Other studies showed that involvement of a
member of the nuclear family especially the mother or
father [20] could improve adherence to HAART and
caregiver report does correlate very well with viral load
and clinical outcomes [27]. HIV/AIDS programs and
community sensitisation interventions should encourage
nuclear family members (if they are alive and well) to-
wards active involvement in caring for their paediatric
HIVAIDs patients. Studies in tropical regions showed
that HIV/AIDs disclosure can improve adherence in
children on HAART [28, 29]. Other studies also con-
firmed that disclosure of HIV status is a major issue for
caregivers [30, 31].
Assessment of quality of life in paediatric HIV/AIDs
patient on HAART
Quality of life was assessed using descriptive data that
collected information on means data variability inferen-
tial statistics of quality of life domains. The highest mean
score was obtained in the psychological domain reflect-
ing caregivers’ assessment of child’s happiness, accept-
ance of child’s bodily appearance and child’s negative
feelings. The lowest score was seen in the social domain
reflecting caregivers’ expressed dissatisfaction from
friends and lack of support from other people with high
variability in psychological and social domain compared
to physical health and environmental health domain.
The lowest mean score in the social domain of this study
is similar to a study conducted in South India [31],
Thailand [32] and China [33]. This shows the need for
continual general public sensitisation, caregiver educa-
tion on the positive effect of treatment compliance and
the need for paediatric treatment prioritisation.
Association of Independent variables and quality of life
domains
A Post-Hoc analysis of HIV status (Positive, Negative and
Don’t Know) of the quality of life domains revealed that
the difference was more significant between the Positive
and Don’t Know for Physical Health and Psychological
Health and between the Positive and Negative for Envir-
onmental Health domain. Higher mean scores were ob-
served for quality of life domains among children
accompanied by HIV positive caregivers compared to chil-
dren accompanied by caregivers that don’t know their sta-
tus. Higher mean scores were also observed for children
that were accompanied by HIV positive caregivers in the
environmental health domain than children accompanied
by HIV negative caregivers. Probably, HIV positive care-
givers were actively involved in sensitisation, and
Table 4 Factors affecting adherence to highly active
antiretroviral therapy
Factors Yes No
N (%) N (%)
Child Related factors
Problem with formulation 52 (72.3) 138 (27.7)
Bitter medication 99 (52.7) 89 (47.3)
Caregiver Related factors
I was away from Home 114 (60.6) 74 (39.4)
Always around child 7 (3.7) 181 (96.3)
Did not want others to see 116 (61.7) 72 (38.3)
Don’t Know how to use medicine 21 (11.2) 167 (88.8)
Too busy and forget 73 (38.8) 115 (61.2)
No money to take child to clinic 107 (56.9) NA
Institutional related Factors
Medicine was not available in the clinic 5 (2.7) NA
NA Not Applicable, means answer was not provided by respondent
Table 5 Association between independent variables and
adherence to HAART
Characteristic Chi-Square value P-Value
Caregiver Grouped Age 1.661 0.197
Caregiver Sex 1.335 0.248
Caregiver HIV/AIDS status 4.347 0.093
Caregiver Relationship 0.250 1.000
Child's nutritional status 0.071 0.789
Child's age 3.174 0.075
Child's sex < 0.010 0.984
Table 6 Transformed Quality of Life (QOL) Domain Scores (N =
188)
QOL Domains Minimum Maximum Mean (SD)
Physical Health 21.4 82.1 56.6 (11.6)
Psychological domain 4.2 91.7 63.1 (17.7)
Social Relationship 12.5 87.5 44.1 (18.2)
Environment 21.9 87.5 57.0 (13.6)
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counselling sessions organised by HIV program, seek in-
formation to improve their health status, are possibly on
antiretroviral treatment themselves and so they can appre-
ciate the need for the use of HAART in the suppression of
viral load of the virus to enhance immunity [34].
Post- Hoc Analysis for caregiver type involved in
paediatric HIVAIDs care revealed significant differences
between the participation of nuclear family and extended
family in the psychological and environmental domains.
A significant difference was observed between the nu-
clear family and the other family type with a higher
mean for nuclear family involvement than the involve-
ment of extended family and other family types. This
can be translated into better health outcomes when a
member of the nuclear family is actively involved in car-
ing for the child. The child’s physical health,
Table 7 Bivariate associations between independent variables and quality of life










< 30 years 56.3 (11.0) 63.9 (15.4) 43.5 (21.9) 58.98 (12.2)
≥ 30 years 56.7 (11.9) 62.8 (18.4) 44.4 (16.9) 56.3 (14.1)
P-value 0.834 0.713 0.772 0.243
Caregiver Sex
Male 56.1 (10.5) 64.9 (14.4) 40.3 (11.7) 58.1 (13.4)
Female 56.8 (12.0) 62.5 (18.6) 45.3 (19.6) 56.7 (13.7)
P-value 0.765 0.444 0.112 0.543
Caregiver HIV status
Positive 58.3 (11.7) 68.2 (14.7) 42.5 (20.2) 59.3 (13.7)
Negative 58.2 (9.5) 61.5 (11.3) 47.2 (16.1) 53.8 (9.7)
Don’t Know 53.3 (12.4) 57.5 (22.6) 44.2((16.6) 56.2 (15.4)
P-value 0.024a < 0.001b 0.397 0.081
Involvement in Nutritional program
Yes 57.0 (11.5) 63.1 (16.9) 44.3 (17.3) 56.2 (12.5)
No 55.3 (12.2) 62.9 (20.2) 43.6 (20.9) 59.5 (16.7)
P-value 0.387 0.929 0.821 0.156
Caregiver type (taking child to clinic)
Parents (Mother/Father/Siblings) 58.0 (10.6) 68.2 (14.8) 43.0 (18.2) 59.7(13.5)
Close relatives (Grandparents /Aunties/Uncles) 55.7 (11.6) 56.9 (17.1) 45.4 (18.2) 53.8 (12.3)
Neighbour/Relative outside home 34.8 (19.6) 26.0 (27.1) 56.3 (12.5) 36.7 (13.1)
P-value < 0.001b < 0.001b 0.280 < 0.001b
Child’s Age
< 5 years 56.7 (10.8) 63.1 (16.5) 47.0 (18.7) 57.8 (13.9)
≥ 5 years 56.5 (12.9) 63.0 (19.5) 39.6 (16.4) 55.7 (13.1)
P-value 0.903 0.973 0.006a 0.312
Child’s Sex
Male 55.2 (12.5) 62.0 (19.2) 44.7 (19.9) 57.0 (15.1)
Female 58.3 (10.3) 64.3 (15.8) 43.5 (16.0) 57.0 (11.7)
P-value 0.63 0.369 0.634 0.989
Adherence status
Adherent 64.6 (8.1) 70.8 (13.0) 47.7 (24.3) 55.7 (12.0)
Non-Adherent 56.1 (11.7) 62.6 (17.9) 43.9 (17.8) 57.1 (13.6)
P-value 0.019a 0.134 0.502 0.742
aSignificant; bVery significant; SD standard deviation; Domain 1(Dom1): Physical Health; Domain 2(Dom2): Psychological Health; Domain 3(Dom3): Social Health
Domain 4(Dom4): Environmental Health
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psychological health and environmental health improved
when an extended family member was involved in caring
for the child than when other family type other than the
nuclear family was involved. This provides an option for
the influence of caregiver type on child’s health in the
absence (or death) of a nuclear family member.
In this study, a backward multiple linear regression
model was used after adjusting for other covariates to
assess the independent variables that showed significant
association with the dependent variables, revealing the as-
sociations below. The significant association between HIV
status and physical health shows that a child accompanied
by a caregiver without knowledge of HIV status had
poorer Physical health than those accompanying care-
givers with knowledge of their HIV status (positive/nega-
tive). Similarly, the results also showed that non-
adherence was strongly correlated with poor physical
health. The results of this study are further emphasised by
UNAIDS best practices [34] and other studies on adher-
ence which indicate a positive relationship between aware-
ness and good health [28]. It is therefore important to
ensure that caregivers of children with HIV/AIDS have
knowledge of their HIV status because of its positive im-
pact on the quality of life and the child’s adherence. This
should aim at providing information about the influence
of the knowledge of HIV status among caregivers and the
possibility for improved health of paediatric patient on
HAART. HIVAIDS program should use an opt-out testing
for caregivers of paediatric patients.
Counselling sessions must focus on the reason for the
use of HIV medications and their benefit in improving
the quality of life of the paediatric age group. Caregivers
must be informed about the high level of adherence re-
quired for the achievement of better physical health and
good quality of life of paediatric HIV/AIDS patients.
The results of this study revealed that a child’s poor
psychological health was more associated with whether
the caregiver is from the extended family, as seen in a
study in Kenya [35]. A study on paediatric HIV disclos-
ure did not find statistically significant differences be-
tween pre-disclosure and post-disclosure quality of life
[36]. Therefore, disclosure to child should be encouraged
at an appropriate time. Another study in Kenya revealed
a low prevalence of disclosure of HIV status to children
with highlights of how disclosure may be related to key
outcomes such as medication adherence, experiences of
stigma and symptoms of depression [37].
Table 8 Backward multiple linear regression analyses of factors significantly associated with quality of life of paediatric HIV/AIDs
patient on HAART























Coef: Unstandardized Beta value; Domain 1(Dom1): Physical Health; Domain 2(Dom2): Psychological Health; Domain 3 (Dom3): Social Health Domain 4 (Dom4):
Environmental Health
Table 9 Correlation coefficients (CC) in two quality of life
questions and four domains of the WHOQOL-BREF
Q1 Q2 Dom1 Dom2 Dom3 Dom4
Q1 CC 1 0.750 0.626 0.719 0.221 0.407
P-value < 0.001 < 0.001 < 0.001 0.002 < 0.001
Q2 CC 1 0.727 0.794 0.29 0.455
P-value < 0.001 < 0.001 < 0.001 < 0.001
Dom1 CC 1 0.806 0.323 0.551
P-value < 0.001 < 0.001 < 0.001
Dom2 CC 1 0.335 0.628
P-value < 0.001 < 0.001
Dom3 CC 1 0.238
P-value 0.001
Dom4 CC 1
CC: Correlation Coefficient; significant P-value at less than 0.05;
Q1: How can you rate your child’s quality of Life
Q2: How satisfied are you with your child’s health
Domain 1(Dom1): Physical Health; Domain 2(Dom2): Psychological Health;
Domain 3(Dom3): Social Health Domain 4(Dom4): Environmental Health
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The study also showed that poor social health is more
associated with children age group greater than or equal
to 5 years. This may be because of the commencement
of schooling amongst this age group. A Nigerian study
showed that schooling could also account for the factors
contributing to poor adherence amongst children [38].
The regression model did not show any association be-
tween social health and the independent variables. The
results of this study revealed that children had poor en-
vironmental health when the caregiver was a member of
the extended family compared to when a nuclear family
was involved.
Assessment of bias
The method of caregiver report to assess adherence is
widely used in adherence studies in low resource settings
despite its possibility of overestimating adherence mea-
sures [39]. Other methods that can be used to assess the
level of adherence are pill count, biological markers,
medication event monitoring tool and other measures
like pharmacy refill. There is need for further studies
with the use of other measures of adherence rather than
self-reporting by caregivers in order to provide more re-
liable evidence of measures of adherence among paediat-
ric HIV/AIDS patients on HAART in these hospitals.
Strengths and limitations of the study
The study demonstrates good internal consistency for the
WHOQOL-BREF. Cronbach’s alpha value for assessing
the reliability was 0.769 for the four quality of life domain
scores. The validity was assessed using Pearson’s Correl-
ation Coefficient with statistically significant correlations
found among two overall quality of life questions and the
four domains, and most correlations greater than 0.4.
Similar findings were reported in other studies with low
social domain correlation values though significant [19,
22, 23] and in paediatric age group using the GHAC ques-
tionnaire that also uses the quality of life domains as in
the WHOQOL-BREF [32]. The demographic data and ad-
herence questionnaire had also been used in several other
studies that measure the adherence and quality of life of
paediatric HIV/AIDS patients [20, 32].
To date, no study had been conducted in Sierra Leone
to determine the quality of life of paediatric HIV/AIDS
patients on Highly Active Antiretroviral Therapy and its
association to therapeutic adherence. This study is a
cross-sectional study of caregivers that fulfilled the in-
clusion criteria during the study period in the two hospi-
tals, with a good sample size of 188 relatives to the
available data of 383 children [13] that are receiving
antiretroviral therapy in Sierra Leone. The result of this
study is conservative and may not be used to generalise
the whole population because of the small sample size
and or the convenience sampling method used. These
limitations should be considered when interpreting the
results of this study.
The study was able to detect a statistically significant
association with other variables, which suggests that it
had enough power to be able to detect their association
with adherence and/or quality of life.
Conclusion
The study revealed a high percentage of non-adherence
among paediatric HIV/AIDS patients receiving Highly Ac-
tive Antiretroviral Therapy. The study showed that know-
ledge of HIV status, the involvement of nuclear family and
HAART adherence is key for the improvement of physical
health, while the involvement of nuclear family as a care-
giver is key for improvement of psychological and envir-
onmental health. Therefore, the involvement of a member
of the nuclear family in the treatment of children with
HIV/AIDS and caregivers’ knowledge of their HIV status
can improve adherence to treatment and improve quality
of life of children living with HIV/AIDS.
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